Search clinical trials for: letrozole plus leuprolide

Total 5777 results

Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaborators

Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Fibrolamellar Carcinoma | Fibrolamellar Liver Cancer

United States
University of Washington
National Cancer Institute (NCI)

Terminated

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute
Novartis; Beth Israel Deaconess Medical Center

Completed

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Breast Cancer

United States
Assiut University

Recruiting

Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome

Infertility, Female

Egypt
Assiut University

Unknown

Letrozole in Assisted Reproductive Technology

to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .

Egypt
Zagazig University

Completed

Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome

Focus of Study

Egypt
Fengzhi Feng

Recruiting

Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Recurrent Ovarian Carcinoma

China
University of Utah
University of Chicago; University of Michigan

Completed

Follicle-Stimulating Hormone (FSH) and the Onset of Puberty

Precocious Puberty | Delayed Puberty

United States
Hunan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer

Metastatic Breast Cancer

China
Borstkanker Onderzoek Groep
Novartis; Philips Healthcare

Active, not recruiting

Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. (NEOLBC)

Breast Neoplasms

Netherlands
Abbott

Completed

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Puberty, Precocious

United States, Puerto Rico
Enteris BioPharma Inc.
Syneos Health; Parexel

Recruiting

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Endometriosis

United States
Enteris BioPharma Inc.
Syneos Health

Completed

A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Endometriosis

Canada
Foresee Pharmaceuticals Co., Ltd.
QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Puberty; Precocious, Central

United States, China, Taiwan, Puerto Rico
The Affiliated Hospital of Qingdao University
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer

Breast Cancer
Novartis Pharmaceuticals
Roche - Prof. Dr. Jens Huober et al.

Terminated

Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer (eLEcTRA)

Metastatic Breast Cancer

Germany
Camurus AB

Completed

Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

Prostate Cancer

Finland, Hungary
Pfizer

Completed

Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

Breast Cancer

Japan
Cairo University

Completed

Ovulation Induction in Clomiphene Citrate Resistant PCO Women

Polycystic Ovary Syndrome | Infertility

Egypt
Abbott
Fraktal.com.pl; Med-net.pl

Completed

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) (LEMON)

Lower Urinary Tract Symptoms | Advanced Prostate Cancer

Poland, Ukraine
Xichun Hu

Completed

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Wake Forest University Health Sciences

Completed

Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study

Infertility
Helsinki University Central Hospital
Foundation for Paediatric Research, Finland

Completed

Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment (CDGP)

Constitutional Delay of Growth and Puberty

Finland
M.D. Anderson Cancer Center
TAP Pharmaceutical Products Inc.

Completed

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Amenorrhea | Premature Ovarian Failure | Ovarian Function Insufficiency

United States
Foresee Pharmaceuticals Co., Ltd.

Completed

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer

Prostatic Neoplasms

Korea, Republic of, United States, Lithuania, Slovakia, Czechia
San Bernardino Urological Associates Medical Group...

Completed

A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer

Cancer of Prostate

United States
Queensland Fertility Group

Unknown

GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist Cycles (GALA)

Infertility

Australia
GP-Pharm

Completed

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Prostate Cancer

United States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
Foresee Pharmaceuticals Co., Ltd.

Completed

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Prostatic Neoplasms

Czechia, United States, Poland, Austria, Germany, Lithuania, Slovakia, Taiwan
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); University of Ottawa; Queen's...

Completed

PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial (PROOF)

Cancer | Fertility Preservation

Canada
GP-Pharm

Terminated

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

Prostate Cancer

United States
Voyager Pharmaceutical Corporation

Completed

ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation

Alzheimer Disease

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)

Breast Cancer

United States, Puerto Rico
University of Chicago

Completed

Leuprolide in Treating Adults With Hypogonadotropism

Hypogonadism

United States
Guangdong Provincial People's Hospital

Unknown

Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer

Breast Cancer

China
Asan Medical Center

Completed

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer (LEO)

Metastatic Breast Cancer

Korea, Republic of
Midwestern Regional Medical Center

Unknown

NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer (NEOADAPT)

Breast Neoplasms

United States
Tolmar Inc.

Completed

Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

Precocious Puberty, Central

United States, Canada, Argentina, Chile, Mexico, New Zealand
University of Patras

Completed

GnRH-a on Angiogenesis of Endometriosis

Endometriosis | Angiogenesis

Greece, Japan
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Impact of Hot Flashes on Sleep and Mood Disturbance

Depression | Hot Flashes | Menopause

United States
Voyager Pharmaceutical Corporation

Completed

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

Alzheimer Disease

United States
Abbott

Completed

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Prostatic Neoplasms

United States
University of Connecticut
Organon

Completed

The Use of GnRH Agonist Trigger in the Prevention of OHSS

Ovarian Hyperstimulation Syndrome

United States
Schober, Justine, M.D.
TAP Pharmaceutical Products Inc.

Unknown

Lupron Sex Offender Therapy

Pedophilia

United States
Rovi Pharmaceuticals Laboratories

Recruiting

Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women (LEILA-1)

Healthy

Czechia
Bharat Serums and Vaccines Limited

Completed

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

Advanced Prostate Adenocarcinoma

India
Lahey Clinic

Completed

Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion

Dry Eye Syndrome

United States
Daewoong Pharmaceutical Co. LTD.

Recruiting

Evaluate the Efficacy and Safety of DWJ108J

Central Precocious Puberty

Korea, Republic of
AbbVie

Completed

A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

Central Precocious Puberty (CPP)

United States, Puerto Rico
Laboratoires Bouchara-Recordati

Unknown

Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer (LEPTO)

Prostate Cancer

Search clinical trials for: letrozole plus leuprolide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations